Anzeige
Mehr »
Login
Dienstag, 16.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Biotech-Perle kurz vor entscheidender Meilenstein-Meldung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
296 Leser
Artikel bewerten:
(0)

Children's Mercy Researcher In JAMA: Medical System Must Adapt To Better Treat Kids' Chronic Migraines

KANSAS CITY, Mo., Dec. 24, 2013 /PRNewswire/ -- Psychological therapy plus medication appears to be the most effective treatment strategy for chronic migraine in children, but it may take time for the medical system to widely adopt this approach, says an editorial in the current issue of the Journal of the American Medical Association by Mark Connelly, PhD, a pain psychologist and co-director of the Comprehensive Headache Clinic at Children's Mercy Hospital.

(Logo: http://photos.prnewswire.com/prnh/20130904/NY73838LOGO )

Cognitive behavioral therapy can include training on relaxation techniques and cognitive pain coping skills, as well as the use of biofeedback. It has been shown to be a powerful addition to medication for addressing chronic migraine, but reimbursement, limited staffing and lack of specific healthcare professional training are likely to stand in the way of its widespread use, according to Dr. Connelly.

"Even if only half of young people with chronic migraine were able to complete cognitive behavioral therapy, the addition of more than 11 days per month of headache freedom per patient would have a huge impact," said Dr. Connelly, an expert in pediatric pain management. "The medical community will need to be creative to find ways to implement this treatment strategy on a more widespread basis. The benefits at this point are clear."

Chronic migraine is a serious problem for the young, affecting as many as 1 in 60 children and adolescents. Not only are these severe headaches frequent, occurring more than 15 days per month, the symptoms can be overwhelming, including nausea, vomiting, and sensitivity to light and sound. Many of these children experience significant academic, physical and social impairment, yet they rarely receive adequate treatment.

The Comprehensive Headache Clinic at Children's Mercy, which Dr. Connelly co-directs, provides multidisciplinary care for children and teenagers with severe headache disorders such as chronic migraine. The clinic treats patients ages five to 18 who have headaches associated with moderate to severe functional disability or whose headaches have not adequately responded to initial medical treatments.

About Children's Mercy
Children's Mercy, located in Kansas City, Mo., is one of the nation's top pediatric medical centers. The 354-bed hospital provides care for children from birth through the age of 21, and has been ranked by U.S. News & World Report as one of "America's Best Children's Hospitals." For the third time in a row, Children's Mercy has achieved Magnet nursing designation, awarded to fewer than seven percent of all hospitals nationally, for excellence in quality care. Its faculty of 600 pediatricians and researchers across more than 40 subspecialties are actively involved in clinical care, pediatric research, and educating the next generation of pediatric subspecialists. For more information about Children's Mercy and its research, visit childrensmercy.org or download our mobile phone app CMH4YOU for all phone types. For breaking news and videos, follow us on Twitter, YouTube and Facebook.

Jake Jacobson
Phone: (816) 701-4097
Email: jajacobson@cmh.edu

Carin Ganz
Phone: (212) 373-6002
E-mail: cganz@golinharris.com

SOURCE Children's Mercy

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.